CTOR
Citius Oncology, Inc.
1.10$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | +200.0% | +0.0% | – | |
| – | +97,432.4% | -99.9% | +99,900.0% | -14.8% | +8.4% | -99.9% | +1.8% | +108,047.4% | +72.1% | -10.9% | +1.0% | – | |
| – | -90.4% | +167.8% | -77.2% | +74,615.1% | -64.9% | +16.0% | -42.9% | -198.0% | – | – | -94.6% | – | |
| – | -100.0% | – | – | -89.7% | -100.0% | – | – | – | -20.0% | +25.0% | +39,999,900.0% | – | |
| – | +2.0% | – | -100.1% | +128,793.3% | – | – | – | – | -24.1% | -85.0% | +214.3% | – | |
| – | +112.8% | -2,905.0% | – | +7,871.5% | -100.0% | – | – | – | -1.0% | -100.3% | – | – | |
| – | – | -90.6% | -200.0% | – | – | – | – | – | -14.1% | -238.3% | – | – | |
| – | – | – | – | – | -100.0% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.